Don’t Be Fooled And Pay For A Free FDA Calendar (VNDA, AGN, SPPI, INCY)
The Prescription Drug User Fee Act (PDUFA) was enacted in 1992 and renewed in 1997. This act authorized the FDA to charge fees to the drug companies to submit new drugs. The FDA says “user fees have played an important role in expediting the drug approval process”.
The FDA gives a public target date for a NDA (New Drug Application) and other types of submissions under the PDUFA. Some sites actually try and charge you $120 or more for this FREE public information. Dont fall for the scam, this is free public information.
The biotech market is hot right now especially after VNDA’s 900% gain overnight. People are now trying to find the next hidden gem biotech stock that will multiply your investment. These dates from the FDA can be a great time to invest since the stocks can get very volitole and many times stastics are on your side. Just look at how 70%-90% of all drugs that pass Phase 3 testing and are waiting on the FDA’s NDA (New Drug Application) decision are approved.
To help you find the next big biotech stock waiting for FDA approval, we are giving away our FREE FDA Calendar today exclusively to our new forum members of the FavStock.com stock forums. Plus you can stop by our stock market forums and talk about some of the biotech stocks recently in the news such as Vanda Pharmaceuticals Inc. (NASDAQ:VNDA), Allergan, Inc. (NYSE:AGN), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), and Incyte Corporation (NASDAQ:INCY)
By Admin on 07/23/2009 – 6:00 am PST -- Biotech